TrialCancer medicine2021

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trial.

Jing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.